Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial

Journal:
Nature Medicine
Published:
Affiliations:
18
Authors:
44
Institutions Authors Share
Shanghai Changzheng Hospital, SMMU, China
26.333333
26.333333
26.333333
0.60
China Immunotech (Beijing) Biotechnology Co., Ltd., China
4.500000
0.10
Tsinghua University, China
3.166667
0.07
Changhai Hospital, SMMU, China
2.000000
0.05
Changping Laboratory, China
1.333333
0.03
Wenzhou People's Hospital, China
1.000000
0.02
University of Chinese Academy of Sciences (UCAS), China
1.000000
0.02
Wenzhou Medical University (WMU), China
1.000000
0.02
iGeneTech, China
1.000000
0.02
The University of Chicago (UChicago), United States of America (USA)
1.000000
0.02
Drum Tower Hospital, China
1.000000
0.02
Tsinghua - PKU Joint Center for Life Sciences (CLS), China
0.666667
0.02